Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Intercure Ltd (INCR.TO)

Intercure Ltd (INCR.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 273,021
  • Shares Outstanding, K 27,021
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade INCR.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.42
  • Most Recent Earnings 0.44 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance

Most Recent Stories

More News
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U)...

INCR.TO : N/A (unch)
OGI : 0.9022 (-1.42%)
OGI.TO : 1.22 (-3.94%)
INCR-U.TO : 3.77 (+1.34%)
INCR : 3.71 (-6.55%)
InterCure to Release its Q2 2022 Results and Hold a Conference Call

Conference call scheduled for Tuesday, August 16, 2022, at 8:30am ET...

INCR.TO : N/A (unch)
INCR-U.TO : 3.77 (+1.34%)
INCR : 3.71 (-6.55%)
InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth

Estimated revenue reaches CAD$36 million 1(a record NIS 95 million) Anticipates continued increases in EBITDA Revenue growth expected to...

INCR.TO : N/A (unch)
INCR : 3.71 (-6.55%)
INCR-U.TO : 3.77 (+1.34%)
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria

NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the...

INCR.TO : N/A (unch)
INCR-U.TO : 3.77 (+1.34%)
INCR : 3.71 (-6.55%)
InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel

Cookies Be'er Sheva is the largest medical cannabis dedicated pharmacy in Israel...

INCR.TO : N/A (unch)
INCR-U.TO : 3.77 (+1.34%)
INCR : 3.71 (-6.55%)
InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6...

INCR.TO : N/A (unch)
INCR : 3.71 (-6.55%)
INCR-U.TO : 3.77 (+1.34%)
InterCure to Release its Q1 2022 Results and Hold a Conference Call

Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ET...

INCR.TO : N/A (unch)
INCR-U.TO : 3.77 (+1.34%)
INCR : 3.71 (-6.55%)
InterCure to Participate in Upcoming Investor Conferences in May 2022

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba...

INCR.TO : N/A (unch)
INCR-U.TO : 3.77 (+1.34%)
INCR : 3.71 (-6.55%)
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference

NEW YORK and TORONTO and HERZLIYA, Israel, May 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)...

INCR.TO : N/A (unch)
INCR-U.TO : 3.77 (+1.34%)
INCR : 3.71 (-6.55%)
InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results

Another record year with continued industry leading growth and profitability supported by focused strategy and execution Revenue growth expected to...

INCR.TO : N/A (unch)
INCR : 3.71 (-6.55%)
INCR-U.TO : 3.77 (+1.34%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point N/A
1st Resistance Point N/A
Last Price N/A
1st Support Level N/A
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 0.00
Fibonacci 61.8% N/A
Fibonacci 50% N/A
Fibonacci 38.2% N/A
52-Week Low 0.00

See More

Business Summary

Intercure Ltd is a medical company that sells FDA-cleared, non-drug, non-invasive hypertension treatment device RESPeRATE that helps lower blood pressure using paced breathing.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar